Amal Therapeutics
develops and commercializes peptide-based therapeutic vaccines for the treatment of cancer... Read moreAmal Therapeutics
develops and commercializes peptide-based therapeutic vaccines for the treatment of cancer... Read more
News
Jun 12, 2020
European Biotechnology
Amal Therapeutics: AMAL Therapeutics raises 8m
Jul 18, 2019
BioPortfolio
Amal Therapeutics: Expanding Cancer Immunotherapy Focus Boehringer Acquires AMAL Therapeutics for Upto325M httpow.lyrHRu50v4Q5QÂpic.twitter.com3OligckDgh
Jul 17, 2019
BioPortfolio
Amal Therapeutics: Boehringer Ingelheim acquires swiss biotech startup
Jul 16, 2019
startupticker
Amal Therapeutics: Amal Therapeutics becomes a subsidiary of a German Pharma giant
Jul 15, 2019
FinSMEs
Amal Therapeutics: Boehringer Ingelheim Acquires Amal Therapeutics, For Up To €325M
May 03, 2019
startupticker ch
Amal Therapeutics: AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim
Mar 26, 2019
Genomeweb
Amal Therapeutics: Natera, Amal Therapeutics to Monitor Treatment Response in Colorectal Cancer Patients
Nov 14, 2018
BioPortfolio
Amal Therapeutics: Amal bags 21.2m financing
Nov 12, 2018
FierceBiotech
Amal Therapeutics: Boehringer powers cancer vaccine startup Amal to B round
Sep 08, 2017
Global Corporate Venturing
Amal Therapeutics: Amal develops $9.6m series B
Amal Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10